Nelson Jeffrey Edward
Chief Operating Officer
Nelson Jeffrey Edward has filed 1 SEC Form 4 filing (4 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Jan 28, 2026.
On the most recent filing, Nelson Jeffrey Edward is listed as Chief Operating Officer at Milestone Pharmaceuticals Inc. Inside the rolling window, Nelson Jeffrey Edward reported no open-market purchases and 2 open-market sales totaling $158K in MIST. The largest disclosed transaction in the window is a sale of 58,007 MIST shares on Dec 15, 2025, worth $135K.
Companies traded
Other insiders at MIST
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$158K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Nelson Jeffrey Edward made?
Nelson Jeffrey Edward has filed 1 SEC Form 4 filing (4 transaction rows) across 1 company since 2026.
Which companies does Nelson Jeffrey Edward trade?
Nelson Jeffrey Edward has filed SEC Form 4 disclosures for 1 company, including MIST.
When was Nelson Jeffrey Edward's most recent SEC Form 4 filing?
Nelson Jeffrey Edward's most recent SEC Form 4 filing on Tracefour is dated Jan 28, 2026.
What is Nelson Jeffrey Edward's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Nelson Jeffrey Edward is listed as Chief Operating Officer.
What is Nelson Jeffrey Edward's total buy and sell value in the current window?
Inside the rolling retention window, Nelson Jeffrey Edward bought $0 and sold $158K based on SEC Form 4 filings.
What was Nelson Jeffrey Edward's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 58,007 MIST shares on 2025-12-15, worth $135K, per SEC Form 4 filings.